Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core
- Bioorg Med Chem Lett. 2008 Jan 15;18(2):474-8. doi: 10.1016/j.bmcl.2007.11.103.
- 1. Bristol-Myers Squibb R& D, Princeton, NJ 08543-5400, USA. [email protected]
T-type calcium channel antagonists were designed using a protocol involving the program SPROUT and constrained by a ComFA-based pharmacophore model. Scaffolds generated by SPROUT were evaluated based on their ability to be translated into structures that were synthetically tractable. From this exercise, a novel series of potent and selective T-type channel antagonists containing a biaryl sulfonamide core were discovered.